He Tian

Chinese Academy Of Medical Sciences & Peking Union Medical College
Beijing, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Integrated molecular characterization reveals the pathogenesis and therapeutic strategies of pulmonary blastoma.

Integrated molecular characterization reveals the pathogenesis and therapeutic strategies of pulmonary blastoma.

Journal: Journal of the National Cancer Center
Published: November 04, 2023

Genomic characteristics and immune landscape of super multiple primary lung cancer.

Genomic characteristics and immune landscape of super multiple primary lung cancer.

Journal: EBioMedicine
Published: October 30, 2023

Tumor-derived KLK8 predicts inferior survival and promotes an immune-suppressive tumor microenvironment in lung squamous cell carcinoma.

Tumor-derived KLK8 predicts inferior survival and promotes an immune-suppressive tumor microenvironment in lung squamous cell carcinoma.

Journal: BMC pulmonary medicine
Published: October 07, 2023

Single-cell sequencing reveals immune features of treatment response to neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma.

Single-cell sequencing reveals immune features of treatment response to neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma.

Journal: Nature communications
Published: March 28, 2023

Multiple primary lung cancer: Updates of clinical management and genomic features.

Multiple primary lung cancer: Updates of clinical management and genomic features.

Journal: Frontiers in oncology
Published: September 02, 2022

Genetic trajectory and clonal evolution of multiple primary lung cancer with lymph node metastasis.

Genetic trajectory and clonal evolution of multiple primary lung cancer with lymph node metastasis.

Journal: Cancer gene therapy
Published: June 20, 2022

TIGIT/CD47 dual high expression predicts prognosis and is associated with immunotherapy response in lung squamous cell carcinoma.

TIGIT/CD47 dual high expression predicts prognosis and is associated with immunotherapy response in lung squamous cell carcinoma.

Journal: Thoracic cancer
Published: April 01, 2022

PSC subtyping based on TTF-1 and p40 expression reveals distinct molecular characteristics and therapeutic strategies.

PSC subtyping based on TTF-1 and p40 expression reveals distinct molecular characteristics and therapeutic strategies.

Journal: International journal of cancer
Published: November 26, 2021

ERAP2 Is Associated With Immune Infiltration and Predicts Favorable Prognosis in SqCLC.

ERAP2 Is Associated With Immune Infiltration and Predicts Favorable Prognosis in SqCLC.

Journal: Frontiers in immunology
Published: October 04, 2021

A Multi-Center Validated Subtyping Model of Esophageal Cancer Based on Three Metabolism-Related Genes.

A Multi-Center Validated Subtyping Model of Esophageal Cancer Based on Three Metabolism-Related Genes.

Journal: Frontiers in oncology
Published: September 07, 2021

Lipid metabolism-related lncRNA SLC25A21-AS1 promotes the progression of oesophageal squamous cell carcinoma by regulating the NPM1/c-Myc axis and SLC25A21 expression.

Lipid metabolism-related lncRNA SLC25A21-AS1 promotes the progression of oesophageal squamous cell carcinoma by regulating the NPM1/c-Myc axis and SLC25A21 expression.

Journal: Clinical and translational medicine
Published: September 06, 2021

Research Progress of Anti-PD-1/PD-L1 Immunotherapy Related Mechanisms and Predictive Biomarkers in NSCLC.

Research Progress of Anti-PD-1/PD-L1 Immunotherapy Related Mechanisms and Predictive Biomarkers in NSCLC.

Journal: Frontiers in oncology
Published: September 01, 2021
Showing 1-12 of 14

Last Updated: 09/26/2026